1. 2023
  2. SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy

    Kuijper, S. C., Pape, M., Haj Mohammad, N., van Voorthuizen, T., Verhoeven, R. H. A. & van Laarhoven, H. W. M., 15 Mar 2023, In: International Journal of Cancer. 152, 6, p. 1202-1209 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy

    Kuijper, S. C., Pape, M., Haj Mohammad, N., van Voorthuizen, T., Verhoeven, R. H. A. & van Laarhoven, H. W. M., 15 Mar 2023, In: International Journal of Cancer. 152, 6, p. 1202-1209

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer

    Dings, M. P. G., Manoukian, P., Waasdorp, C., Quik, J. S. E., Strijker, M., Lodestijn, S. C., van Neerven, S. M., Moreno, L. F., de Oliveira, R. L., Bonsing, B. A., Bruno, M. J., Busch, O. R., Doukas, M., van Eijck, C. H., Mohammad, N. H., de Hingh, I. H., Molenaar, Q. I., Besselink, M. G., Vermeulen, L., Medema, J. P., & 2 othersvan Laarhoven, H. W. M. & Bijlsma, M. F., 1 Feb 2023, In: International Journal of Cancer. 152, 3, p. 511-523 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data

    Boyd, L. N. C., Ali, M., Leeflang, M. M. G., Treglia, G., de Vries, R., le Large, T. Y. S., Besselink, M. G., Giovannetti, E., van Laarhoven, H. W. M. & Kazemier, G., 1 Jan 2023, In: EClinicalMedicine. 55, 101747.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study

    Kroese, T. E., Takahashi, Y., Lordick, F., van Rossum, P. S. N., Ruurda, J. P., Lagarde, S. M., van Hillegersberg, R., Verhoeven, R. H. A. & van Laarhoven, H. W. M., 1 Jan 2023, In: European Journal of Cancer. 179, p. 65-75 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Effect of physical exercise on the hippocampus and global grey matter volume in breast cancer patients: A randomized controlled trial (PAM study)

    PAM study group, Jan 2023, In: NeuroImage. Clinical. 37, 103292.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival

    van Hoeve, J. C., Verhoeven, R. H. A., Nagengast, W. B., Oppedijk, V., Lynch, M. G., van Rooijen, J. M., Veldhuis, P., Siesling, S. & Kouwenhoven, E. A., Jan 2023, In: European journal of surgical oncology. 49, 1, p. 106-112 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer

    OMEC-working group (Supplementary File 1), Jan 2023, In: European journal of surgical oncology. 49, 1, p. 21-28 8 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  10. Quality of care and quality of life as experienced by patients with advanced cancer of a rare tumour type: results of the multicentre observational eQuiPe study

    van Oss, A., Duijts, S. F. A., van Laarhoven, H., Kuip, E., Raijmakers, N. J. H. & Brom, L., 2023, (E-pub ahead of print) In: Journal of cancer survivorship.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...145 Next

ID: 19925